Chen Rui, Anderson Vernon, Hiroi Yukio, Medof M Edward
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
J Cell Biochem. 2003 Apr 1;88(5):1025-37. doi: 10.1002/jcb.10439.
For characterizing how the glycosylphosphatidylinositol (GPI) transamidase complex functions, we exploited a two-step miniPLAP (placental alkaline phosphatase) in vitro translation system. With this system, rough microsomal membranes (RM) containing either [(35)S]-labeled Gaa1p or epitope-tagged Gpi8p, alternative components of the enzymatic complex, were first prepared. In a second translation, unmodified or mutant miniPLAP mRNA was used such that [(35)S]-labeled native or variant miniPLAP nascent protein was introduced. Following this, the RM were solubilized and anti-PLAP or anti-epitope immunoprecipitates were analyzed. With transamidase competent HeLa cell RM, anti-PLAP or anti-epitope antibody coprecipitated both Gaa1p and Gpi8p consistent with the assembly of the proprotein into a Gaa1p:Gpi8p-containing complex. When RM from K562 mutant K cells which lack Gpi8p were used, anti-PLAP antibody coprecipitated Gaa1p. The proprotein coprecipitation of Gaa1p increased with a nonpermissive GPI anchor addition (omega) site. In contrast, if a miniPLAP mutant devoid of its C-terminal signal was used, no coprecipitation occurred. During the transamidation reaction, a transient high Mr band forms. To definitively characterize this product, RM from K cells transfected with FLAG-tagged GPI8 were employed. Western blots of anti-FLAG bead isolates of solubilized RM from the cells showed that the high Mr band corresponded to Gpi8p covalently bound to miniPLAP. Loss of the band following hydrazinolysis demonstrated that the two components were associated in a thioester linkage. The data indicate that recognition of the proprotein involves Gaa1p, that the interaction with the complex does not depend on a permissive omega site, and that Gpi8p forms a thioester intermediate with the proprotein. The method could be useful for rapid analysis of nascent protein interactions with transamidase components, and possibly for helping to prepare a functional in vitro transamidase system.
为了表征糖基磷脂酰肌醇(GPI)转酰胺酶复合物的功能,我们利用了两步法的微型胎盘碱性磷酸酶(miniPLAP)体外翻译系统。使用该系统,首先制备含有[(35)S]标记的Gaa1p或表位标签化的Gpi8p(酶复合物的替代成分)的粗微粒体膜(RM)。在第二次翻译中,使用未修饰的或突变的miniPLAP mRNA,从而引入[(35)S]标记的天然或变体miniPLAP新生蛋白。此后,将RM溶解,并分析抗PLAP或抗表位免疫沉淀产物。对于具有转酰胺酶活性的HeLa细胞RM,抗PLAP或抗表位抗体共沉淀了Gaa1p和Gpi8p,这与前体蛋白组装成含Gaa1p:Gpi8p的复合物一致。当使用来自缺乏Gpi8p的K562突变K细胞的RM时,抗PLAP抗体共沉淀了Gaa1p。前体蛋白与Gaa1p的共沉淀随着非允许性GPI锚定添加(ω)位点而增加。相反,如果使用缺乏其C末端信号的miniPLAP突变体,则不会发生共沉淀。在转酰胺反应过程中,会形成一个瞬时的高分子量条带。为了明确表征该产物,使用了转染了FLAG标签化GPI8的K细胞的RM。对细胞中溶解的RM的抗FLAG磁珠分离物进行的蛋白质印迹分析表明,高分子量条带对应于与miniPLAP共价结合的Gpi8p。肼解后该条带消失,表明这两个成分以硫酯键相连。数据表明,前体蛋白的识别涉及Gaa1p,与复合物的相互作用不依赖于允许性的ω位点,并且Gpi8p与前体蛋白形成硫酯中间体。该方法可能有助于快速分析新生蛋白与转酰胺酶成分的相互作用,并可能有助于制备功能性的体外转酰胺酶系统。